This year's Update in Oncology incorporates articles on breast cancer, lung cancer, immune response, prostate cancer, multiple myeloma, and colon cancer.
Dose-Dense Therapy Improved Clinical Outcomes in Node-Positive Breast Cancer Citron ML, Berry DA, Cirrincione C, et al. Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741. J Clin Oncol. 2003;21:1431-9. [PMID: 12668651]The standard of care for patients with node-positive breast cancer involves administering a predefined course of adjuvant chemotherapy (for patients without ...
Author, Article, and Disclosure Information
Steven H. Stein,
From University of Pennsylvania, Philadelphia, and GlaxoSmithKline, Collegeville, Pennsylvania.
Contributing Editor: Jennifer Fisher Wilson.
Disclosures: None disclosed.
Corresponding Author: Steven H. Stein, MD, GlaxoSmithKline, 1250 South Collegeville Road, UP 4420, PO Box 5089, Collegeville, PA 19426.